Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein tyrosine phosphatase non-receptor type 11B, pseudogene (PTPN11BP), is a non-coding genomic locus classified as a transcribed unprocessed pseudogene located on human chromosome 1[3][7][5][2][4]. It does not encode a protein product and has no described biological function or clinical relevance as a therapeutic target. Its functional, protein-coding homolog, PTPN11, encodes the phosphatase SHP2, which has established roles in cell signaling and oncogenesis, but PTPN11BP itself does not have any such activity and is not considered a drug target. Important note: Please do not confuse "PTPN11BP" (pseudogene, no function) with "PTPN11" (protein-coding, important proto-oncogene and cancer target)[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein tyrosine phosphatase non-receptor type 11B, pseudogene (PTPN11BP).